Search Results - "Moreno–Grau, Sonia"
-
1
Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Published in Scientific reports (22-02-2021)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
2
A genome‐wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)
Published in Liver international (01-10-2019)“…Background A low proportion of individuals repeatedly exposed to the hepatitis C virus (HCV) remain uninfected. This condition could have a genetic basis but…”
Get full text
Journal Article -
3
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
Published in Scientific reports (19-03-2021)“…Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion to Alzheimer’s disease (AD) and other dementia types in patients…”
Get full text
Journal Article -
4
Visual impairment in aging and cognitive decline: experience in a Memory Clinic
Published in Scientific reports (18-06-2019)“…Visual impairment is common in people living with dementia and regular ophthalmological exams may improve their quality of life. We evaluated visual function…”
Get full text
Journal Article -
5
Meta‐GWAS of amyloid burden endophenotype combining PET and CSF results
Published in Alzheimer's & dementia (01-12-2021)“…Background It is well known that Alzheimer’s disease (AD) has a strong genetic component. Even though it is a highly heritable disease, a big fraction of AD…”
Get full text
Journal Article -
6
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Published in Scientific reports (18-11-2020)“…To date, very few studies have been focused on the impact of the convergence of neuropsychiatric symptoms (NPS) and APOE ε4 on the conversion to dementia in…”
Get full text
Journal Article -
7
Polygenic risk score portability for common diseases across genetically diverse populations
Published in Human genomics (02-09-2024)“…Polygenic risk scores (PRS) derived from European individuals have reduced portability across global populations, limiting their clinical implementation at…”
Get full text
Journal Article -
8
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results
Published in Alzheimer's & dementia (01-05-2018)“…Subjective cognitive decline (SCD) has been proposed as a potential preclinical stage of Alzheimer's disease (AD). Nevertheless, the genetic and biomarker…”
Get full text
Journal Article -
9
Impact of Recruitment Methods in Subjective Cognitive Decline
Published in Journal of Alzheimer's disease (01-01-2017)“…Recruitment methods can determine sample characteristics in mild cognitive impairment and Alzheimer's disease dementia, but little is known about its influence…”
Get more information
Journal Article -
10
Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
Published in Frontiers in aging neuroscience (08-12-2021)“…Mild cognitive impairment is often associated with affective and other neuropsychiatric symptoms (NPS). This co-occurrence might have a relevant impact on…”
Get full text
Journal Article -
11
Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research
Published in Human genomics (08-09-2022)“…A major challenge to enabling precision health at a global scale is the bias between those who enroll in state sponsored genomic research and those suffering…”
Get full text
Journal Article -
12
A polygenic risk score for mosaic loss of chromosome Y susceptibility is associated with higher risk of MCI to AD conversion
Published in Alzheimer's & dementia (01-12-2021)“…Background Mosaic loss of chromosome Y (mLOY) is a highly common somatic variant among men, and has been associated to higher risk in overall mortality and…”
Get full text
Journal Article -
13
Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain
Published in Journal of Alzheimer's disease (01-01-2020)“…The COVID-19 pandemic has brought great disruption to health systems worldwide. This affected ongoing clinical research, particularly among those most…”
Get more information
Journal Article -
14
GENETIC RISK FOR SCHIZOPHRENIA AND PSYCHOSIS IN ALZHEIMER DISEASE
Published in Alzheimer's & dementia (01-07-2017)Get full text
Journal Article -
15
PGS-Explorer: A web-based meta-analysis tool for polygenic scores
Published in Journal of clinical oncology (01-06-2023)“…e13538 Background: In clinical cancer prevention, polygenic score models (PGS) have focused on the aggregation of effects from multiple genetic variants. PGS…”
Get full text
Journal Article -
16
Genome research in pre-dementia stages of Alzheimer's disease
Published in Expert reviews in molecular medicine (30-05-2016)“…Genetic characterization of individuals at risk of Alzheimer's disease (AD), i.e. people having amyloid deposits in the brain without symptoms, people…”
Get more information
Journal Article -
17
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project
Published in Alzheimer's & dementia (01-10-2019)“…Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Genome…”
Get full text
Journal Article -
18
The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease
Published in Molecular psychiatry (01-02-2021)“…In Alzheimer’s disease (AD), a single-nucleotide polymorphism in the gene encoding brain-derived neurotrophic factor ( BDNF Val66Met ) is associated with worse…”
Get full text
Journal Article -
19
Genetic architecture of neurodegenerative dementias
Published in Neuropharmacology (15-05-2020)“…Molecular genetics has been an invaluable tool to help understand the molecular basis of neurodegenerative dementias. In this review, we provide an overview of…”
Get full text
Journal Article -
20
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease
Published in Molecular psychiatry (01-10-2021)“…Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects…”
Get full text
Journal Article